« Back to the previous page

Also available in:

Pharmaceutical CRO wanted in Europe

Company to buy

  • Size: small- to medium-sized business
  • Revenue: 5 – 15M EUR
  • Location of the Pharmaceutical CRO Company: Europe
  • Reason for acquisition: The management is expanding the business
  • EBITDA of the target: 10%+
  • #CFIE PHB200

Overview of the pharmaceutical CRO wanted in Europe  

The management of a leading European pharmaceutical company is expanding the company’s business and is looking for pharmaceutical contract research organizations (CROs) to acquire in Europe. The company should be a CRO or be specialized in eClinical solutions. The buyer is open to any kind of M&A project, including acquisition, merger, or other formal relationship or investment.

Profile (strategy) of the pharmaceutical CRO buyer

The buyer is an international pharmaceutical company which is able to provide full development services of pharma project from co-developing phase to late phase and post approval phase. The company provides truly international services, with clinical development and related services provided in over 34 countries. With revenue over 12M EUR and EBITDA of more than 2M EUR, the buyer is financially stable and will cover the acquisition out of own funds. The buyer is really acquisitive with over 4 acquisitions in recent years.
The management is looking for target companies with a strong expertise and with synergies to exploit. The possible synergies include coverage of African Continent, strong business presence in India and very strong international relationships. The planned acquisition can start right away after finding a suitable target.

Sell your pharmaceutical
CRO company

Contact us to get details about this buyer of pharmaceutical CRO company in Europe

Activities and products of the pharmaceutical CRO target company

The target company should be preferably a CRO or eClinical Solutions company. The company can also be specialized in any other stats or regulatory type business in Europe. target should have its own stable employees, preferably from 30 to 100 skilled professionals.
The EBITDA of the target should be higher than 10%. The target company should be from Europe, the exact region is not specified.
The buyer is specifically looking for potential targets with strong Eastern European reach, and attractive customer base in Eastern Europe, which can the buyer utilize. The target should be strong also in the clinical trial management system.

Highlights of the pharmaceutical CRO wanted in Europe  

  • The buyer is a pharmaceutical company with large capital backing
  • The buyer is highly acquisitive with over 4 acquisitions in recent years
  • The target should be a CRO or eClinical solutions specialized company in Europe

Information of the pharmaceutical CRO wanted in Europe 

Feel free to contact us for more information regarding this pharmaceutical contract research organization wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.